Sun Y - Search Results

1

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer.

Wu YL, Park K, Soo RA, Sun Y, Tyroller K, Wages D, Ely G, Yang JC, Mok T. Wu YL, et al. Among authors: sun y. BMC Cancer. 2011 Oct 7;11:430. doi: 10.1186/1471-2407-11-430. BMC Cancer. 2011. PMID: 21982342 Free PMC article. Clinical Trial.

2

[Efficacy and safety of Erlotinib in the treatment for advanced non-small cell lung cancer in Chinese patients].

Wu YL, Liao ML, Qin SK, Sun Y, Zhou CC. Wu YL, et al. Among authors: sun y. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):148-51. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403248 Clinical Trial. Chinese.

3

Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens.

Paz-Ares L, Hirsh V, Zhang L, de Marinis F, Yang JC, Wakelee HA, Seto T, Wu YL, Novello S, Juhász E, Arén O, Sun Y, Schmelter T, Ong TJ, Peña C, Smit EF, Mok TS. Paz-Ares L, et al. Among authors: sun y. J Thorac Oncol. 2015 Dec;10(12):1745-53. doi: 10.1097/JTO.0000000000000693. J Thorac Oncol. 2015. PMID: 26743856 Free article. Clinical Trial.

4

[Efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy].

Sun Y, Wu YL, Li LY, Liao ML, Jiang GL, Kim ES, Douillard JY, Milenkova T. Sun Y, et al. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):377-80. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875470 Chinese.

5

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.

Wu YL, Lee JS, Thongprasert S, Yu CJ, Zhang L, Ladrera G, Srimuninnimit V, Sriuranpong V, Sandoval-Tan J, Zhu Y, Liao M, Zhou C, Pan H, Lee V, Chen YM, Sun Y, Margono B, Fuerte F, Chang GC, Seetalarom K, Wang J, Cheng A, Syahruddin E, Qian X, Ho J, Kurnianda J, Liu HE, Jin K, Truman M, Bara I, Mok T. Wu YL, et al. Among authors: sun y. Lancet Oncol. 2013 Jul;14(8):777-86. doi: 10.1016/S1470-2045(13)70254-7. Epub 2013 Jun 17. Lancet Oncol. 2013. PMID: 23782814 Clinical Trial.

6

Survival without common toxicity criteria grade 3/4 toxicity following second-line treatment with pemetrexed for nonsquamous non-small cell lung cancer in Chinese patients.

Wu YL, Sun Y, Zhou CC, Zhang L, Yu SY, Ma SL, Han LL, Zhang XQ, Orlando M. Wu YL, et al. Among authors: sun y. Chin Med J (Engl). 2013;126(24):4624-8. Chin Med J (Engl). 2013. PMID: 24342300

7

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, Sun Y, Liao ML, Osterlind K, Reck M, Armour AA, Shepherd FA, Lippman SM, Douillard JY. Kim ES, et al. Among authors: sun y. Lancet. 2008 Nov 22;372(9652):1809-18. doi: 10.1016/S0140-6736(08)61758-4. Lancet. 2008. PMID: 19027483 Clinical Trial.

8

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.

Shi Y, Zhang L, Liu X, Zhou C, Zhang L, Zhang S, Wang D, Li Q, Qin S, Hu C, Zhang Y, Chen J, Cheng Y, Feng J, Zhang H, Song Y, Wu YL, Xu N, Zhou J, Luo R, Bai C, Jin Y, Liu W, Wei Z, Tan F, Wang Y, Ding L, Dai H, Jiao S, Wang J, Liang L, Zhang W, Sun Y. Shi Y, et al. Among authors: sun y. Lancet Oncol. 2013 Sep;14(10):953-61. doi: 10.1016/S1470-2045(13)70355-3. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948351 Clinical Trial.

9

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.

Sun Y, Cheng Y, Hao X, Wang J, Hu C, Han B, Liu X, Zhang L, Wan H, Xia Z, Liu Y, Li W, Hou M, Zhang H, Xiu Q, Zhu Y, Feng J, Qin S, Luo X. Sun Y, et al. BMC Cancer. 2016 Apr 9;16:265. doi: 10.1186/s12885-016-2301-6. BMC Cancer. 2016. PMID: 27061082 Free PMC article. Clinical Trial.

10

[Weekly administration of gemcitabine and docetaxel combinations in the treatment of advanced non-small cell lung cancer].

Li J, Wu Y, Li L, Gu L, Zhang L, Wang J, Zhang X, Sun Y. Li J, et al. Among authors: sun y. Zhongguo Fei Ai Za Zhi. 2003 Oct 20;6(5):375-7. doi: 10.3779/j.issn.1009-3419.2003.05.13. Zhongguo Fei Ai Za Zhi. 2003. PMID: 21306683 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,104 results

Search Page

Filters